Genzyme's new incentives

In another of several recent moves to appease its restive shareholder base, last week Genzyme Corp. (NASDAQ:GENZ) adopted a new executive incentive plan and gave more power to its lead independent director.

Annual incentives for senior executives will be based on corporate and individual performance. The former will be measured via revenue and cash flow return on invested capital, as well as business objectives, pipeline advancements and the recovery of the personalized genetic health business...